The future of HF management: How does potassium binding fit within pharmacological treatment of heart failure?
June 28, 2016 - ESC HF 2016, Florence, Italy - Kenneth Dickstein, MD - University of Bergen Stavanger University Hospital, Norway
The complex and increasing burden of heart failure 0:01
Heart failure seen from a neurohumoral perspective 2:54
Higher aldosterone levels in response to diuretic therapy 4:08
Patients with elevated serum creatinine benefit most from ramipril treatment in the HOPE trial 6:49
Hyperkalemia in the context of blockade of the renin-angiotensin system 7:17
Hyperkalemia hampers adequate guideline-indicated management of HF 13:00